TGFB1 and neoplasm: Beyond autocrine TGF-β and IL-10, tumor cells in the microenvironment also downregulate DC surface MHC-II and CCR7 expression by secreting IL-10, IL-6, and others, thereby disrupting antigen presentation (93).